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Abstract
Successful empirical therapy of Staphylococcus aureus infections requires the
ability to predict methicillin resistance. Our aim was to identify predictors of
methicillin resistance in community-onset (CO) invasive S. aureus infections.
Sixteen hospitals across Korea participated in this study from May to December
2012. We prospectively included cases of S. aureus infection in which S. aureus
was isolated from sterile clinical specimens#72 hours after hospitalization. Clinical
and epidemiological data were gathered and compared in methicillin-resistant S.
aureus (MRSA) and methicillin-susceptible S. aureus (MSSA) cases. Community-
associated (CA) infections were defined as in previous studies. In total, there were
786 cases of community-onset S. aureus infection, 102 (13.0%) of which were CA-
MRSA. In addition to known risk factors, exposure to 3rd generation cephalosporins
in the past 6 months [odds ratio (OR), 1.922; 95% confidence interval (CI), 1.176–
3.142] and close contact with chronically ill patients in the past month (OR, 2.647;
95% CI, 1.189–5.891) were independent risk factors for MRSA infection. However,
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no clinical predictors of CA-MRSA were identified. Methicillin resistance, CO
infection, and appropriateness of empirical antibiotics were not significantly related
to 30-day mortality. MRSA infection should be suspected in patients recently
exposed to 3rd generation cephalosporins or chronically-ill patients. There were no
reliable predictors of CA-MRSA infection, and mortality was not affected by
methicillin resistance.
Introduction
Infections caused by methicillin-resistant Staphylococcus aureus (MRSA) have
been reported worldwide in individuals without apparent healthcare-associated
(HA) risk factors [1]. The term ‘‘community-associated MRSA’’ (CA-MRSA) has
been coined to distinguish the clinical and microbiological features of these
infections from traditional HA-MRSA [2]. CA-MRSA was the most common
identifiable cause of skin and soft tissue infections (SSTIs) among patients treated
in US emergency rooms, and most clones were of the USA300 pulsed-field type
containing Panton-Valentine leucocidin (PVL) [3]. However, the prevalence and
characteristics of CA-MRSA vary with geographical location [4].
Although MRSA is endemic in Korean hospitals, cases of CA-MRSA have not
been common [5]. In studies to date, the most prevalent CA-MRSA clone was
sequence type 72, staphylococcal chromosomal cassette mec type IVa (ST72-
SCCmec IVa) without the PVL gene [5, 6]. However, this clone is likely to have
become more common in recent years, not only in the community but also in
hospitals [7, 8], but there has been no large scale multicenter study on the
epidemiological changes of CA-MRSA infections in Korea since 2005.
The ability to predict methicillin resistance in invasive community-onset (CO)
S. aureus infections is necessary for successful empirical treatment. The Centers
for Disease Control and Prevention (CDC) in the USA has defined the clinical
criteria for risk factors associated with MRSA acquisition to distinguish CA-
MRSA from HA-MRSA [9], and these can guide clinicians in their initial choice of
empirical antibiotic in cases of suspected invasive MRSA infections. However, it is
not clear whether empirical anti-MRSA drugs should be considered in suspected
cases of invasive CO-S. aureus infections in Korea. It may be difficult to
distinguish cases of CA-MRSA without recognizable risk factors from CA-MSSA.
No predictors of CA-MRSA infection have been clearly identified in previous
prospective studies, all of which were single-center [10–12].
This multicenter nationwide cross-sectional study was performed to evaluate
epidemiological changes in invasive CA-MRSA infections in Korea. We also tried
to identify clinical and epidemiological risk factors for methicillin resistance in
patients with invasive CO-S. aureus infections, which are important for more
rational anti-MRSA antibiotic use.
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Materials and Methods
Study design and population
Sixteen hospitals across Korea participated in this eight-month study from May to
December 2012. To identify cases of invasive S. aureus infection, infectious
diseases specialists at each hospital regularly screened microbiological cultures
that would normally be expected to be sterile for the presence of S. aureus.
Patients were enrolled if their culture was positive for S. aureus, and samples for
culture were collected within 72 hours of hospitalization. If a patient had more
than one invasive S. aureus infection during the study period, only the first
incident was included as a study case. Patients who were discharged from the
hospital or who died before it was possible to confirm S. aureus infection
microbiologically were excluded from the analysis. The study was approved by the
Institutional Review Board at each participating hospital: All participating
institutions were in the Republic of Korea. 1) Seoul National University Bundang
Hospital Institutional Review Board, Seongnam, 2) Seoul National University
Hospital Institutional Review Board, Seoul, 3) Pusan National University Hospital
Institutional Review Board, Busan, 4) Chonnam National University Hospital
Institutional Review Board, Gwangju, 5) Daegu Fatima Hospital Institutional
Review Board, Daegu, 6) Ajou University Hospital Institutional Review Board,
Suwon, 7) Institutional Review Board of Inje University Busan Paik Hospital,
Busan, 8) Boramae Hospital Institutional Review Board, Seoul, 9) Ewha Womans
University Mokdong Hospital Institutional Review Board, Seoul, 10)
Soonchunhyang University Seoul Hospital Institutional Review Board, Seoul, 11)
Soonchunhyang University Bucheon Hospital Institutional Review Board,
Bucheon, 12) Yonsei University Wonju Severance Christian Hospital Institutional
Review Board, Wonju, 13) Soonchunhyang University Cheonan Hospital
Institutional Review Board, Cheonan, 14) Institutional Review Board of Chonbuk
National University Hospital, Jeonju, 15) Chonnam National University Hwasun
Hospital Institutional Review Board, Hwasun, 16) Pusan National University
Yangsan Hospital Institutional Review Board, Yangsan. The informed consents
were waived.
Definitions
Isolation of S. aureus and antibiotic susceptibility testing were performed in the
clinical microbiology laboratory of each participating hospital using an automated
system. Invasive S. aureus infection was diagnosed when S. aureus was isolated
from a normally sterile body fluid, as defined previously [13]. The infection was
classified as community-onset (CO) if the S. aureus-positive specimen was
obtained within 72 hours of hospitalization. It was classified as community-
associated (CA) if the specimen was not from a site of previous surgery, and none
of the established healthcare-associated (HA) risk factors for MRSA acquisition or
infection were present [9, 11, 14]. These included: (1) history of hospitalization
(excluding birth of normal newborns) or surgery within 1 year of the S. aureus-
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positive culture; (2) history of residence in a long-term care facility within the past
year; (3) history of hemodialysis or peritoneal dialysis within the past year; and (4)
presence of a permanent indwelling catheter or percutaneous medical device at
the time of culture. The cases that did not fully meet these criteria were classified
as CO-HA S. aureus infections.
In each case, the type of S. aureus infection was confirmed clinically by an
infectious diseases specialist at each hospital and classified as one of the following:
central line-associated bloodstream infection (CLA-BSI), pneumonia, SSTI,
surgical site infection (SSI), bone and joint infection (BJI), otitis, endocarditis,
intra-abdominal infection (IAI), urinary tract infection (UTI), central nervous
system (CNS) infection, vascular infection including arteriovenous fistula (AVF)
infection, and bacteremia of unknown primary focus. Cases of pneumonia, SSTI,
UTI, and otitis were included only when S. aureus was isolated from sterile body
fluids such as blood or surgical specimen. Antibiotic therapy was considered
appropriate if the isolate was susceptible to the chosen antibiotic in vitro and the
treatment was administered for at least 24 hours within 72 hours of hospitaliza-
tion.
Data collection
All data were collected prospectively. Infectious diseases specialists at each hospital
reviewed the patients’ medical records and interviewed the enrolled patients using
a standardized clinical record form. Among the data collected were (1)
demographic findings, (2) clinical characteristics, including the Charlson
comorbidity index [15] and 30-day mortality, and (3) microbiological data. We
also gathered diverse epidemiological data to assess new potential risk factors for
MRSA infection.
Statistical analysis
We assumed the prevalence of any risk factor for CA-MRSA to be 15%, and the
difference in prevalence between CA-MRSA and CA-MSSA to be 10%. We also
hypothesized that the ratio of CA-MRSA to CA-MSSA would be 1:2. To achieve a
0.80 level of statistical power with a two-sided alpha error of 0.05, we estimated
that the study should last at least 8 months to allow the 16 hospitals to enroll a
total of 296 cases of CA-S. aureus infection. The sample size was calculated using
Epi Info version 7 developed by the CDC and the estimate of study duration was
based on the number of invasive S. aureus cases recorded at each hospital during
the previous year.
Statistical analyses were performed with PASW Statistics, version 18.0.0.
Univariate analyses were performed to screen for potential risk factors (using
Student’s t-test and the x2 test or Fisher’s exact test, depending on the type of
variable), with P values ,0.10 considered statistically significant for inclusion in
the multivariate analysis. Multivariate linear logistic regression models were
formulated and tested to adjust for covariates. Adjusted odds ratios (ORs) and
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their 95% confidence intervals (CIs) were calculated, with P values ,0.05
considered statistically significant.
Results
Surveillance
The 16 participating hospitals are spread across the country. All are teaching
hospitals; 15 (93.8%) are university-affiliated, and 8 (50.0%) have 900 or more
beds. Two of the hospitals participated for 6 months only, from May to October
2012. A total of 1627 cases of invasive S. aureus infection were recorded during the
study period, and 786 cases of CO-S. aureus infection were included in the
analysis after excluding 811 hospital onset cases and 30 cases in which patients
were discharged or died before microbiological confirmation of S. aureus infection
(Fig. 1). Among the 786 cases included, 322 cases (41.0%) were CA infections and
464 (59.0%) were HA infections. The most common specimen from which S.
aureus was isolated was blood (68.3%). Other specimen types were abscesses in
internal body sites (13.4%), bone and organ tissue (6.7%), joint fluid (5.5%), ear
discharge (1.8%), pleural fluid (1.7%), ascites (1.3%), CSF (1.3%), and pericardial
fluid (0.1%).
Clinical characteristics and antibiotic susceptibility
The clinical characteristics of the 786 patients with CO-S. aureus infections are
summarized in Table 1. The patients were older and there were more
comorbidities among the HA infection group than among the CA group. The
most common infections were SSTI in the CA-MRSA group, BJI in the CA-MSSA
group, and pneumonia in the HA-MRSA group.
A comparison of their antibiotic susceptibility profiles showed that the CA-
MRSA isolates (n5102) were more susceptible to non-beta-lactam agents such as
erythromycin, clindamycin, ciprofloxacin, rifampin, and tetracycline than the
HA-MRSA isolates (n5253), but the same was not true for sulfamethoxazole-
trimethprim and gentamicin (Fig. 2).
Risk factors for methicillin resistance
Among the 786 invasive CO-S. aureus infections, 431 were caused by MSSA and
355 by MRSA. The risk factors for methicillin resistance identified in univariate
analysis are shown in Table 2. According to our multivariate logistic regression
model, factors associated with an increased risk of invasive CO-MRSA infection
included residence in a long-term care facility within the past year, history of SSI
within the past year, history of MRSA carriage within the past year, recent (in the
past 6 months) exposure to 3rd generation cephalosporins, and history of close
contact with patients with chronic illnesses within the past month when compared
to CO-MSSA infection (Table 3).
Factors Associated with Community-Onset Invasive MRSA Infections
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Figure 1. Schematic diagram describing the classification of Staphylococcus aureus infections as
community-associated (CA) or healthcare-associated (HA) according to methicillin-resistance (MRSA)
or methicillin susceptibility (MSSA).
doi:10.1371/journal.pone.0114127.g001
Table 1. Baseline characteristics of 786 cases of community-onset invasive Staphylococcus aureus infection in Korea according to epidemiological features
and methicillin resistance.
Characteristics CA-Infections HA-Infections
CA-MRSA (n5102) CA-MSSA (n5220) HA-MRSA (n5253) HA-MSSA (n5211)
Sex (M:F) 61:41 135:85 151:102 130:81
Age, years (mean ¡ SD) 46.2¡26.2 49.1¡26.4 61.2¡21.2 59.2¡19.4
Range 0–89 0–94 0–100 0–100
Type of infection
Primary bacteremia 14 (13.7%) 39 (17.7%) 32 (12.6%) 27 (12.8%)
CLA-BSI 0 (0%) 0 (0%) 20 (7.9%) 20 (9.5%)
Pneumonia 4 (3.9%) 17 (7.7%) 51 (20.2%) 20 (9.5%)
SSTI 34 (33.3%) 52 (23.6%) 30 (11.9%) 43 (20.4%)
SSI 0 (0%) 0 (0%) 26 (10.3%) 18 (8.5%)
BJI 19 (18.6%) 72 (32.7%) 39 (15.4%) 44 (20.9%)
Otitis 14 (13.7%) 11 (5.0%) 3 (1.2%) 0 (0%)
Endocarditis 5 (4.9%) 12 (5.5%) 5 (2.0%) 3 (1.4%)
IAI 4 (3.9%) 9 (4.1%) 22 (8.7%) 20 (9.5%)
UTI 4 (3.9%) 5 (2.3%) 6 (2.4%) 4 (1.9%)
CNS infection 4 (3.9%) 3 (1.4%) 4 (1.6%) 3 (1.4%)
Vascular infection 0 (0%) 0 (0%) 15 (5.9%) 8 (3.8%)
Others 0 (0%) 0 (0%) 0 (0%) 1 (0.5%)
Comorbidities
None 72 (70.6%) 135 (61.4%) 49 (19.4%) 43 (20.4%)
Charlson index (mean ¡ SD) 0.5¡1.2 0.7¡1.2 2.5¡2.2 2.5¡.3
CA, community-associated; HA, healthcare-associated; MRSA, methicillin-resistant S. aureus; MSSA, methicillin-susceptible S. aureus; CLA-BSI, central
line associated blood stream infection; SSTI, skin and soft tissue infection; SSI, surgical site infection; BJI, bone and joint infection; IAI, intra-abdominal
infection; UTI, urinary tract infection; CNS, central nervous system.
doi:10.1371/journal.pone.0114127.t001
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In a univariate analysis of 322 cases of invasive CA-S. aureus infections, we
compared the risk factors for CA-MRSA and CA-MSSA. While SSTIs and otitis
were more common in the patients with CA-MRSA, BJIs were more common in
those with CA-MSSA (Table 4). However, no risk factor could differentiate
significantly between CA-MRSA and CA-MSSA.
Clinical outcomes
We were able to assess 30-day mortality in 660 (84.0%) patients, having excluded
126 patients who were transferred or discharged without outpatient follow-up
within 30 days of admission. The 30-day mortality rate was 15.3% (101/660)
among the patients with invasive CO-S. aureus infections. The factors associated
with 30-day mortality were older age, higher Charlson comorbidity index, and
pneumonia or primary bacteremia (Table 5). However, appropriateness of the
initial choice of antibiotic, and resistance of S. aureus to methicillin were not
significantly associated with mortality. CA infections were significantly associated
with lower mortality in the univariate analysis, but not in the multivariate model
in CO-S. aureus infections.
Discussion
Of the 1012 cases of invasive MRSA, 102 (10.1%) were caused by CA-MRSA,
which is a considerably higher proportion than estimated in previous surveillance
studies in Korea (5.3–5.9%) [5. 8]. A similar increase in CA-MRSA has been
Figure 2. Antibiotic susceptibility profiles of the community-associated methicillin-resistant
Staphylococcus aureus (CA-MRSA) isolates and the healthcare-associated MRSA (HA-MRSA)
isolates. ERY, CLI, CIP, RIF, SUL, GEN, TET, VAN, and TEI denote erythromycin, clindamycin, ciprofloxacin,
rifampin, sulfamethoxazole-trimethoprim, gentamicin, tetracycline, vancomycin, and teicoplanin, respectively.
Data for CIP, RIF, SUL, GEN, TET, and TEI were missing for 2, 1, 34, 4, 2, and 1 patient(s), respectively. * and
** indicate statistical significance at P,0.05 and 0.01, respectively (x2 test).
doi:10.1371/journal.pone.0114127.g002
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Table 2. Univariate analysis of risk factors for methicillin resistance in 786 cases of community-onset invasive Staphylococcus aureus infection.
Characteristics MSSA (n5431) MRSA (n5355) P Value OR (95% CI)
Male gender 265 (61.5%) 212 (59.7%) 0.614 1.077 (0.808–1.435)
Age, years (mean ¡ SD) 54.0¡23.8 56.9¡23.7 0.091
Age (per 10-year increase) 0.091 1.053 (0.992–1.118)
Age group, years 0.074
#15 49 (11.4%) 38 (10.7%)
16-64 207 (48.0%) 145 (40.8%)
$65 175 (40.6%) 172 (48.5%)
Previous admission (,1 yr) 171 (39.7%) 204 (57.5%) ,0.001 2.054 (1.544–2.733)
Residence in a long -term care facility (,1 yr) 20 (4.6%) 44 (12.4%) ,0.001 2.907 (1.680–5.033)
History of dialysis (,1 yr) 34 (7.9%) 43 (12.1%) 0.047 1.609 (1.002–2.584)
History of SSI (,1 m) 11 (2.6%) 23 (6.5%) 0.007 2.654 (1.271–5.504)
Presence of percutaneous devices 37 (8.6%) 50 (14.1%) 0.014 1.746 (1.112–2.739)
Underlying illness 253 (58.7%) 234 (65.9%) 0.038 1.361 (1.017–1.821)
Charlson index (mean ¡ SD) 1.6¡2.0 1.9¡2.1 0.015
Charlson index (per 1 unit increase) 0.016 1.087 (1.016–1.164)
Previous MRSA carriage (,1 yr) 8 (1.9%) 46 (13.0%) ,0.001 7.871 (3.663–16.915)
Previous antibiotic exposure (,6 m)
Any antibiotic 109 (25.3%) 161 (45.4%) 0.001 2.452 (1.814–3.314)
Any cephalosporins 61 (14.2%) 95 (26.8%) 0.001 2.216 (1.548–3.172)
1st generation cephalosporins 19 (4.4%) 21 (5.9%) 0.339 1.363 (0.721–2.578)
2nd generation cephalosporins 5 (1.2%) 5 (1.4%) 0.761 1.217 (0.350–4.238)
Cephamycin 4 (0.9%) 6 (1.7%) 0.360 1.835 (0.514–6.555)
3rd generation cephalosporins 33 (7.7%) 68 (19.2%) ,0.001 2.858 (1.836–4.449)
4th generation cephalosporins 5 (1.2%) 4 (1.1%) 1.000 0.971 (0.259–3.643)
Quinolones 16 (3.7%) 35 (9.9%) ,0.001 2.837 (1.543–5.217)
Immunosuppressant use (,1 yr) 26 (6.0%) 20 (5.6%) 0.813 0.930 (0.510–1.696)
Steroid use 8 (1.9%) 9 (2.5%) 0.515 1.375 (0.525–3.602)
History of acupuncture (,1 m) 26 (6.0%) 17 (4.8%) 0.445 0.783 (0.418–1.468)
History of OPD visit (,1 yr)a
Any number of visits 285 (66.7%) 260 (74.1%) 0.026 1.424 (1.042–1.945)
1–4 visits/yr 90 (31.6%) 96 (36.9%)
5–9 visits/yr 60 (21.1%) 47 (18.1%)
10–19 visits/yr 64 (22.5%) 51 (19.6%)
20–29 visits/yr 31 (10.9%) 25 (9.6%)
30–49 visits/yr 7 (2.5%) 6 (2.3%)
.49 visits/yr 5 (1.8%) 15 (5.8%)
Unknown 28 (9.8%) 20 (7.7%)
Close contact with HCWs (,1 m) 111 (25.8%) 135 (38.0%) ,0.001 1.769 (1.305–2.398)
Close contact with chronically-ill patients (,1 m) 10 (2.3%) 24 (6.8%) 0.002 3.053 (1.440–6.473)
Living with children #5 years oldb 66 (23.2%) 64 (25.9%) 0.461 1.160 (0.781–1.724)
Current smoking 54 (12.5%) 32 (9.0%) 0.116 0.692 (0.436–1.098)
Alcohol intakec 94 (22.3%) 57 (16.7%) 0.051 0.696 (0.483–1.003)
None 327 (77.7%) 285 (83.3%)
,20 g/day 38 (9.0%) 23 (6.7%)
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observed in North America, in both children and adults [16–18]. Since the 2000s,
CA-MRSA has been the most common identifiable cause of purulent SSTIs in
patients treated in US emergency departments [19]. The prescribing practices of
clinicians for treating SSTIs in emergency departments have changed as a result,
from MRSA-inactive to MRSA-active empirical antimicrobial regimens. An
MRSA-targeted choice of empirical antibiotics is not yet common in emergency
rooms in Korea because there have been no data supporting this strategy.
However, we should be aware that guidance about the appropriate antibiotic
usage may become important as numbers of CA-MRSA cases rise.
Previously established risk factors for MRSA acquisition in other studies were
also significant in our univariate analysis (Table 2) [9, 11, 14]. However, only
three remained significant in the multivariate model: residence in a long-term care
facility within the past year, history of SSI within the past month, and history of
MRSA carriage within the past year (Table 3). Additionally, exposure to 3rd
generation cephalosporins within the past six months and close contact with
chronically-ill patients within the past month were found to be significant risk
factors for CO-MRSA infection in a multivariate analysis. Recent antibiotic
exposure has been identified as a significant risk factor for methicillin resistance in
CO-S. aureus infections in other studies [12, 20, 21]. Use of fluoroquinolones has
been considered a particularly important predictor of nosocomial MRSA
Table 2. Cont.
Characteristics MSSA (n5431) MRSA (n5355) P Value OR (95% CI)
20–40 g/day 15 (3.6%) 11 (3.2%)
$40 g/day 41 (9.7%) 23 (6.7%)
Communal living 10 (2.3%) 21 (5.9%) 0.010 2.647 (1.230–5.698)
Participation in extreme sports 10 (2.3%) 3 (0.8%) 0.107 0.359 (0.098–1.314)
Data are numbers (%) of patients unless stated otherwise. Values in bold indicate factors with statistical significance (P,0.10). MSSA, methicillin-
susceptible S. aureus; MRSA, methicillin-resistant S. aureus; SD, standard deviation; SSI, surgical site infection; OPD, outpatient department; HCW,
healthcare worker.
aData on OPD visits for 8 patients were censored, and 778 patients (427 and 351 patients in the MSSA and MRSA groups, respectively) were included in the
analysis.
bData on living with children #5 years old for 254 patients were censored, and 532 patients (285 and 247 patients in the MSSA and MRSA groups,
respectively) were included in the analysis.
cData on alcohol intake for 23 patients were censored, and 763 patients (421 and 342 patients in the MSSA and MRSA groups, respectively) were included
in the analysis.
doi:10.1371/journal.pone.0114127.t002
Table 3. Multivariate analysis of risk factors for methicillin-resistant Staphylococcus aureus (MRSA) infection in patients with community-onset invasive S.
aureus infection.
Characteristics P Value Adjusted OR (95% CI)
Residence in a long-term care facility (,1 yr) 0.008 2.438 (1.258–4.726)
History of surgical site infection (,1 m) 0.022 2.481 (1.138–5.410)
Previous MRSA carriage (,1 yr) ,0.001 5.565 (2.501–12.381)
Previous use of 3rd generation cephalosporins (,6 m) 0.009 1.922 (1.176–3.142)
Close contact with chronically-ill patients (,1 m) 0.017 2.647 (1.189–5.891)
doi:10.1371/journal.pone.0114127.t003
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Table 4. Univariate analysis of risk factors for methicillin-resistant Staphylococcus aureus (MRSA) infection among 322 patients with community-associated
invasive S. aureus infection in Korea.
Characteristics CA-MSSA (n5220) CA-MRSA (n5102) P Value OR (95% CI)
Male gender 135 (61.4%) 61 (59.8%) 0.790 1.068 (0.661–1.725)
Age, years (mean ¡ SD) 46.2¡26.2 49.1¡26.4 0.369
Age (per 10-year increase) 0.368 0.960 (0.879–1.049)
Age group
#15 yr 40 (18.2%) 20 (19.6%) 0.879 1.098 (0.604–1.994)
16–64 yr 101 (45.9%) 55 (53.9%) 0.663 1.379 (0.861–2.208)
$65 yr 79 (35.9%) 27 (26.5%) 0.121 0.643 (0.382–1.080)
Type of infection
Primary bacteremia 39 (17.7%) 14 (13.7%) 0.460 0.738 (0.381–1.431)
Pneumonia 17 (7.7%) 4 (3.9%) 0.218 0.487 (0.160–1.487)
SSTI 52 (23.6%) 34 (33.3%) 0.090 1.615 (0.964–2.701)
BJI 72 (32.7%) 19 (18.6%) 0.013 0.471 (0.265–0.834)
Otitis 11 (5.0%) 14 (13.7%) 0.013 3.023 (1.321–6.919)
Endocarditis 12 (5.5%) 5 (4.9%) 0.951 0.894 (0.306–2.607)
AI 9 (4.1%) 4 (3.9%) 0.816 0.957 (0.288–3.183)
UTI 5 (2.3%) 4 (3.9%) 0.637 1.755 (0.461–6.678)
CNS infections 3 (1.4%) 4 (3.9%) 0.292 2.952 (0.648–13.443)
Presence of comorbidities 85 (38.6%) 30 (29.4%) 0.108 0.662 (0.399–1.097)
Charlson index (mean ¡ SD) 1.2¡0.7 1.2¡0.5 0.211
Charlson index (per 1 unit increase) 0.214 0.867 (0.693–1.086)
Previous MRSA carriage (,1 yr) 0 2 (2.0%) 0.100 -
Previous antibiotic exposure (,6 m)
Any 20 (9.1%) 7 (6.9%) 0.502 0.737 (0.301–1.803)
Cephalosporins 5 (2.3%) 5 (4.9%) 0.298 2.216 (0.627–7.934)
Quinolones 1 (0.5%) 0 (0%) 1.000 -
Immunosuppressant use (,1 yr) 5 (2.3%) 0 (0%) 0.183 -
Steroid use 2 (0.9%) 0 (0%) 1.000 -
History of acupuncture (,1 m) 15 (6.8%) 10 (9.8%) 0.352 1.486 (0.643–3.431)
History of OPD visit (,1 yr)a 121 (55.5%) 65 (65.0%) 0.111 1.489 (0.912–2.430)
Close contact with HCWs (,1 m) 36 (16.4%) 22 (21.6%) 0.258 1.406 (0.778–2.540)
Close contact with chronically-ill patients (,1 m) 3 (1.4%) 2 (2.0%) 0.654 1.447 (0.238–8.794)
Living with children #5 years oldb 36 (24.3%) 16 (27.6%) 0.628 1.185 (0.596–2.357)
Current smoking 34 (15.5%) 11 (10.8%) 0.261 0.661 (0.320–1.365)
Alcohol intakec 59 (27.7%) 26 (26.5%) 0.830 0.943 (0.550–1.617)
Communal living 2 (0.9%) 1 (1.0%) 1.000 1.079 (0.097–12.040)
Participation in extreme sports 9 (4.1%) 1 (1.0%) 0.179 0.232 (0.029–1.857)
Data are number (%) of patients unless stated otherwise. Values in bold indicate factors with statistical significance (P,0.10). CA, community-associated;
MSSA, methicillin-susceptible S. aureus; SD, standard deviation; SSTI, skin and soft tissue infection; BJI, bone and joint infection; IAI, intra-abdominal
infection; UTI, urinary tract infection; CNS, central nervous system; OPD, outpatient department; HCWs, healthcare workers.
aData on OPD visits for 4 patients were censored, and 318 patients (218 and 100 patients in the MSSA and MRSA groups, respectively) were included in the
analysis.
bData on living with children #5 years old for 116 patients were censored, and 206 patients (148 and 58 patients in the MSSA and MRSA groups,
respectively) were included in the analysis.
cData on alcohol intake for 11 patients were censored, and 311 patients (213 and 98 patients in the MSSA and MRSA groups, respectively) were included in
the analysis.
doi:10.1371/journal.pone.0114127.t004
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infections [22, 23], while exposure to 3rd generation cephalosporins was a risk
factor in a case-control study in a Japanese geriatric hospital [24]. Although
exposure to broad-spectrum antibiotics was also an independent risk factor in our
study, it remains likely that antibiotic use is simply an indicator of exposure to HA
environments. Further research is needed to clarify the association of methicillin
resistance with exposure to diverse antibiotics in community-onset S. aureus
infections.
Another predictor of MRSA infection in our study was recent close contact with
a chronically-ill patient. Such patients are much more likely than the general
population to have been exposed to hospital environments or invasive procedures.
In the traditional family model in Korea, the primary caregivers for patients with
chronic illnesses are often family members even after hospitalization [25]. Rates of
S. aureus transmission from patients to household members reportedly range
from ,10% to 43% [26]. Transmission of CA-MRSA within the family has also
been reported [27]. Taken together, growing evidence suggests that family
members or primary caregivers for patients with chronic conditions could be at
increased risk of acquiring MRSA. It is possible that younger children, with their
relatively poor understanding of hygiene and their susceptibility to infections,
might easily transmit MRSA in the community, but they are not associated with
methicillin resistance in our study.
The Charlson comorbidity index was related to methicillin resistance in
univariate analysis but not in multivariate analysis. Other host-related factors such
as age or gender were also unrelated to methicillin resistance. Diabetes was found
to be a predictive factor for MRSA colonization or infection in some studies
[28, 29]. However, it did not differ significantly between MRSA and MSSA
infections among either CA- or HA-infections in this study.
Table 5. Analysis of risk factors for 30-day mortality in community-onset invasive Staphylococcus aureus infections in Korea.
Characteristics Survived (n5559) Deceased (n5101) OR (95% CI) Adjusted OR (95% CI)
Male gender 337 (60.3%) 59 (58.4%) 1.081 (0.703–1.662)
Age, years (mean ¡ SD) 51.7¡24.2 71.8¡12.3
Age (per 10-year increase) 1.977 (1.640–2.384) 1.686 (1.345–2.112)
Type of infection
SSTI 132 (23.6%) 6 (5.9%) 0.204 (0.088–0.477) Reference
Pneumonia 41 (7.3%) 35 (34.7%) 6.700 (3.988–11.255) 8.674 (3.232–23.280)
BJI 137 (24.5%) 11 (10.9%) 0.376 (0.196–0.725) 1.859 (0.641–5.390)
Primary bacteremia 62 (11.1%) 31 (30.7%) 3.550 (2.156–5.844) 9.274 (3.485–24.683)
CA infections 241 (43.1%) 25 (24.8%) 0.434 (0.268–0.703) 1.095 (0.556–2.157)
Charlson index (per 1 unit increase) 1.320 (1.207–1.443) 1.303 (1.123–1.512)
Appropriate choice of initial antibiotics 410 (73.3%) 66 (65.3%) 0.685 (0.437–1.075)
Methicillin resistance 252 (45.1%) 51 (50.5%) 1.243 (0.813–1.899)
Data are number (%) of patients unless stated otherwise. Values in bold indicate factors with statistical significance (P,.05). Out of 786 patients, 660 were
enrolled in the study, and the outcomes of 126 patients (16.2%) could not be evaluated mainly because of transfer or discharge without follow-up within 30
days of admission. SD, standard deviation; SSTI, skin and soft tissue infection; BJI, bone and joint infection; CA, community-associated.
doi:10.1371/journal.pone.0114127.t005
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Previous studies investigating the predictors of CA-MRSA among patients
without any known risk factors for MRSA were performed in single centers and
failed to identify reliable and distinguishable factors [10–12]. Despite our
improved study design (multi-center, large-scale, nationwide prospective study),
we also found no significant clinical or epidemiological factors that distinguish
between CA-MSSA and CA-MRSA. We cannot rule out the possibility that
important factors have been missed. However, it is also possible that identifying
distinguishing features of CA-MRSA in Korea may be more difficult than in other
populations because the same MRSA clones are frequently present in the hospital
setting and in the community [5, 7].
We have in addition compared the variables for HA-MRSA (n5253) and HA-
MSSA (n5211) infections in the same way as in CA-infections (S1 Table and S2
Table). In multivariate analysis, history of MRSA carriage within the past year,
exposure to 3rd generation cephalosporins within 6 months, and history of close
contact with patients with chronic illnesses within the past month were
statistically significant risk factors for methicillin resistance in CO-HA-S. aureus
infections, as in the analysis of whole CO-S. aureus infections. The only
distinguishing factor favoring MRSA infection in this setting was presentation as
pneumonia (odds ratio 1.975, 95% confidential interval 1.073–3.633). Two recent
studies of the clinical characteristics of infections caused by the ST72-SCCmec IV
strain, which is the most common genotype of CA-MRSA in Korea, also found
that pneumonia was one of the leading diagnoses among CO-MRSA infections
[30, 31].
CA infection, methicillin resistance, and appropriateness of initial choice of
antibiotic did not seem to affect 30-day mortality in this study. When we stratified
the cases as CA-infections or HA-infections, methicillin resistance and appro-
priateness of antibiotic choice again had no significant effect on 30-day mortality.
Instead 30-day mortality was primarily related to patient’s status and severity of
infection. A recent Austrian study identified higher patient age, pneumonia as the
type of infection, and failure to use an MRSA-active antimicrobial agent, as
significant risk factors for early mortality from MRSA bacteremia [32]. However,
two Taiwanese studies of CA- or CO-S. aureus bacteremia showed that 30-day
mortality rates were not affected by community origin, methicillin resistance, or
the initial choice of empirical antibiotics, which is consistent with our findings
[33, 34]. We suggest that clinicians can safely defer prescribing empirical
glycopeptides in cases of suspected invasive CO-S. aureus infections when no risk
factors for MRSA infection are present and bacteremia or pneumonia is not
clinically suspected.
This study has potential limitations. First, the number of CA-MRSA cases may
have been underestimated because we included only those that were confirmed
microbiologically. Because microbiological confirmation is frequently difficult in
SSTIs, and most of the CA-MRSA clones in Korea do not produce the PVL toxin,
it is possible that some cases of SSTI were missed [5, 6, 35]. It is worth noting,
however, that SSTIs comprised 33% of the CA-MRSA infections included
(Table 1). This is not only consistent with a previous Korean study [5], but also
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suggests that the risk of missing SSTIs was in fact low. Second, as we excluded
patients who were discharged or died before microbiological confirmation of S.
aureus infection, a selection bias cannot be ruled out. However, the excluded cases
comprised only 3.7% (30/816) of the total, and the rates were similar in the MRSA
and MSSA groups. Third, the findings associated with 30-day mortality in our
study should be interpreted with caution because we did not include data for
those patients who died before their infection was confirmed microbiologically,
and 126 patients (16%) were not followed up for a full 30 days after
hospitalization. However, neither the exclusion rates before microbiological
confirmation (14/369 vs 16/447, P50.98) nor the rates of loss to follow-up within
30 days of hospitalization (104/353 vs 127/418, P50.84) differed between the
MRSA and MSSA groups. Fourth, our results may not convey a complete picture
of the disease in the community because all the participating centers were
secondary or tertiary hospitals. Fifth, we did not evaluate a seasonal variation in S.
aureus infections because the study period was only 8 months long. Finally, we did
not analyze the genetic background of the MRSA isolates. The antibiotic
susceptibility profiles of the CA-MRSA and HA-MRSA isolates for non-beta-
lactams were significantly different (Fig. 2). However, it was not possible to infer
potential common genetic types of MRSA from their profiles because the most
common nosocomial MRSA strains such as ST5 and ST239 are also circulating in
the Korean community [5]. Despite these limitations, the study has definite
strengths, such as its large-scale, prospective, and nationwide design.
In conclusion, CA-MRSA cases have increased in Korea since the last
nationwide survey in 2005. The risk of MRSA infection should be considered
where there has been recent exposure to 3rd generation cephalosporins, or close
contact with chronically-ill patients. We do not recommend universal empirical
anti-MRSA treatment in patients presenting with invasive CO-S. aureus infections
in Korea if there are no risk factors for methicillin resistance. Clinicians should
consider empirical anti-MRSA treatment only in the clinical setting of severe
illness.
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